AstraZeneca Sponsors the 2011 National Senior Games

Third-Time Gold Medal Sponsor will send nine employee athletes to compete in Houston

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) joined the National Senior Games Association to launch competition at the 2011 National Summer Senior Games in Houston, the largest multi-sport event in the world for men and women age 50 and older.

As a leading healthcare company, AstraZeneca promotes healthy choices at every stage of life and the company’s Gold Medal sponsorship of the Senior Games aligns with this mission.

“The athletes who compete at the Senior Games embody the benefits of leading a healthy, active lifestyle, and their competitive spirit and dedication to sport is truly admirable,” said David Nicoli, Vice President, Corporate Affairs. “We hope that all who attend the competition this year will leave inspired and with a renewed energy to actively manage their health and to help those around them do the same.”

From June 16-30, more than 10,000 athletes will compete in 18 sports. There are nine AstraZeneca employee athletes competing in the 2011 Summer Games:

  • Deborah Anzalone, M.D., Table Tennis
  • Lynne Bever, Volleyball
  • Robert Biros, Track and Field
  • Michelle Bracken, Swimming
  • Linda Jarjisian, Track and Field
  • Katherine Karageorges-Sharp, Swimming
  • Wayne Michelcavage, Volleyball
  • Mark Quinton, Archery
  • Zhiping You, Badminton

AstraZeneca also will sponsor the Celebration of Athletes event at the George R. Brown Convention Center on June 21, as well as the AstraZeneca Athlete Village, where athletes and spectators can participate in healthy activities ranging from cooking demonstrations to dancing to exercise classes at the AstraZeneca Display.

Health and sports enthusiasts of all ages are invited to follow AstraZeneca during the Senior Games on Twitter at @AstraZenecaUS (#SeniorGames), via the company blog at www.azhealthconnections.com and on Facebook at www.faceboook.com/AstraZenecaUSCommunityConnections.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).



CONTACT:

AstraZeneca
Tony Jewell, 302-885-4594
or
Lynn Shepherd, 302-885-8911

KEYWORDS:   United States  North America  Delaware

INDUSTRY KEYWORDS:   Health  Pharmaceutical

MEDIA:

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.